PEDIATRICS Vol. 74 No. 3 September 1984, pp. 444-445
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WOODY, R. C.
Right arrow Articles by WEINBERG, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WOODY, R. C.
Right arrow Articles by WEINBERG, W. A.

Use of Tricyclic Medications in Children

ROBERT C. WOODY MD1, RICHARD LIVINGSTON MD2, and WARREN A. WEINBERG MD3

1 Department of Pediatrics and Neurology, University of Arkansas for Medical Sciences, Little Rock, AR 72205
2 Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock
3 Department of Pediatrics and Neurology, University of Texas Southwestern Medical School, Dallas

To the Editor.—

The recent report by Rauber and Maroncelli summarizing the results of a mail survey of pediatricians and family practitioners regarding their knowledge and usage of tricyclic medications1 demonstrates two points: (1) the pediatricians surveyed rarely (0.9%) used tricyclic medications for psychopharmacologic purposes in their practices, and (2) their knowledge of the toxic side effects (defined by Rauber and Maroncelli as tachycardia and seizures) is limited (67%). The authors state that the standard use of tricyclic medications, such as imipramine for enuresis, represents "the use of a dangerous drug for the treatment of a nonlethal disease."